Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group.

About a third of semaglutide users achieved both inflammation reduction and scarring improvement, more than double compared to those taking the placebo. The drug also helped participants with weight ...

There are currently no drugs approved in the European Union to treat the liver condition known as MASH, but a new trial of ...

The semaglutide group achieved a weight loss of 10.5% at 72 weeks compared with 2% for adults receiving placebo (estimated difference, –8.5 percentage points; 95% CI, –9.6 to –7.4 ...

Semaglutide effectively treats liver disease in two thirds of patients, new research has found. Results from the ESSENCE ...

How Long Does It Take for Semaglutide to Work? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide is the active ingredient in the weight loss medication Wegovy and the ...

New research shows that semaglutide, the compound in the weight-loss drug Wegovy ... semaglutide injections and around 34% of those on placebo shots saw the fat and inflammation in their livers ...

The cutting-edge weight-loss drug ... taking semaglutide stopped their fatty liver disease without further scarring of the organ -- 63%, compared with 34% of those taking a placebo, researchers ...

The diabetes and weight loss ... taking a placebo, scientists reported June 8 in a small clinical trial in the New England Journal of Medicine. That’s in line with the new semaglutide trial ...

versus 22.4% in the placebo group. Participants treated with semaglutide also saw improvements in liver enzymes and blood measures of liver fibrosis, as well as 10.5% weight loss. Some adverse ...